Glucose-6-Phosphate Dehydrogenase anticorps (AA 351-450) (Cy3)

N° du produit ABIN1415056

Détail du produit anti-Glucose-6-Phosphate Dehydrogenase anticorps (Cy3)

Antigène: Glucose-6-Phosphate Dehydrogenase (G6PD)

Épitope: AA 351-450

Reactivité: Souris

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Glucose-6-Phosphate Dehydrogenase est conjugé à/à la Cy3

Application: Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Réactivité croisée: Souris

Homologie: Human,Rat,Cow,Sheep,Horse,Rabbit

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human Glucose 6 Phosphate Dehydrogenase

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur Glucose-6-Phosphate Dehydrogenase

Antigène: Glucose-6-Phosphate Dehydrogenase (G6PD)

Autre désignation: Glucose 6 Phosphate Dehydrogenase (G6PD Produits)

Synonymes: anticorps G6PD1, anticorps g6pd, anticorps G6pd, anticorps G6pdx, anticorps g6pdh, anticorps g6pd2, anticorps fj78b06, anticorps wu:fj78b06, anticorps si:dkey-90a13.8, anticorps BA3433, anticorps CORTRD1, anticorps G6PDH, anticorps GDH, anticorps G28A, anticorps G6PD, anticorps Gpdx, anticorps glucose-6-phosphate dehydrogenase, anticorps glucose-6-phosphate 1-dehydrogenase, anticorps glucose-6-phosphate 1-dehydrogenase (G6PD), anticorps glucose-6-P dehydrogenase, anticorps glucose-6-phosphate dehydrogenase L homeolog, anticorps glucose-6-phosphate 1-dehydrogenase Zwf, anticorps hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase, anticorps glucose-6-phosphate dehydrogenase X-linked, anticorps G6PD, anticorps g6pd, anticorps g6pD, anticorps zwf, anticorps LOC100120232, anticorps LACBIDRAFT_188936, anticorps G6pd, anticorps g6pd.L, anticorps CNG03280, anticorps Tb10.70.5200, anticorps H6PD, anticorps G6pdx, anticorps H6pd

Sujet:

Synonyms: G6PD, G6PD_HUMAN, G6PD1, G6pdx, Glucose 6 phosphate 1 dehydrogenase, Glucose-6-phosphate 1-dehydrogenase, MET19, POS10, Zwf1p.

Background: Defects in G6PD are the cause of chronic non-spherocytic hemolytic anemia (CNSHA) . Deficiency of G6PD is associated with hemolytic anemia in two different situations. First, in areas in which malaria has been endemic, G6PD-deficiency alleles have reached high frequencies (1 % to 50 %) and deficient individuals, though essentially asymptomatic in the steady state, have a high risk of acute hemolytic attacks. Secondly, sporadic cases of G6PD deficiency occur at a very low frequencies, and they usually present a more severe phenotype. Several types of CNSHA are recognized. Class-I variants are associated with severe NSHA, class-II have an activity <10 % of normal, class-III have an activity of 10 % to 60 % of normal, class-IV have near normal activity.

Pathways: Regulation of Systemic Arterial Blood Pressure by Hormones